How have ATNFW shares performed this year?

180 Life Sciences' stock was trading at $0.0042 at the start of the year. Since then, ATNFW shares have increased by 85.7% and is now trading at $0.0078. View the best growth stocks for 2024 here .

How do I buy shares of 180 Life Sciences?

Shares of ATNFW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ATNFW

180 Life Sciences (ATNFW) Stock Price, News & Analysis

$0.0078

0.00 (0.00%)

(As of 09/12/2024 ET)

Compare

Today's Range: $0.0058
▼
$0.0091
50-Day Range: $0.0064
▼
$0.0121
52-Week Range: $0.00
▼
$0.03

Volume: 61,108 shs
Average Volume: 107,194 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

Get 180 Life Sciences alerts:

Ad Banyan Hill Publishing

You won’t believe what this ex-Wall Street insider discovered about the election

One ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered something surprising about the presidential elections… It turns out that for the past 64 years, the stock market has soared during election seasons - regardless of whether a Democrat or Republican is elected. In other words, if you're sitting on the sidelines because you're worried about how the market will react to a Trump or Kamala win, you could be missing out on some serious profits.

Learn all about it here.

About 180 Life Sciences Stock (NASDAQ:ATNFW)

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

ATNFW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ATNFW Stock News Headlines

May 16, 2024 | investorplace.com

ATNF Stock Earnings: 180 Life Sciences Reported Results for Q1 2024

See More Headlines

Receive ATNFW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: Pharmaceutical Products
Current Symbol: NASDAQ:ATNFW
CUSIP: N/A
CIK: 1690080
Web: 180lifesciences.com
Phone: 650-507-0669
Fax: N/A
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

Key Executives

Dr. Lawrence Steinman BA (Age 76)
M.D., Ph.D., Co-Founder & Executive Chairman
Comp: $168.75k
Dr. James N. Woody M.D. (Age 82)
Ph.D., CEO & Director
Comp: $617.77k
Mr. Ozan Pamir C.F.A. (Age 32)
CFO & Secretary
Comp: $410.24k
Dr. Jonathan B. Rothbard Ph.D. (Age 71)
Chief Scientific Officer
Comp: $260.34k
Prof. Jagdeep Nanchahal
Co-Founder & Chairman of Clinical Advisory Board
Mr. Jason Assad
Director of IR

Key Competitors

View All Competitors

ATNFW Stock Analysis - Frequently Asked Questions

How have ATNFW shares performed this year?: 180 Life Sciences' stock was trading at $0.0042 at the start of the year. Since then, ATNFW shares have increased by 85.7% and is now trading at $0.0078.
View the best growth stocks for 2024 here.
How do I buy shares of 180 Life Sciences?: Shares of ATNFW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.